Triple PPI therapy filed for new H pylori uses in Japan
This article was originally published in Scrip
Executive Summary
A group of companies has applied to Japan's ministry of health, labour and welfare for the approval of a combined therapy comprising three proton pump inhibitors and anti-infectives for the eradication of Helicobacter pylori infections in three new clinical settings.